Mr. Redard is a seasoned executive with over 30 years of experience in financial operations, strategic planning and capital markets. His career has spanned a broad range of industries including medical devices, healthcare, consumer products, and manufacturing. Prior to CURE, Redard held CFO, vice president and general manager positions with several venture and private equity backed companies including Inogen, Medical Analysis Systems (acquired by Thermo Fisher Scientific), CDTi Advanced Materials, and Abrisa Technologies. Earlier experience includes management roles with Pepsi and in public accounting. He is a CPA (inactive) and received his B.S. in Business Administration from California Polytechnic State University, San Luis Obispo.